Indian steel and aluminium exporters are likely to face sharp pricing pressure in the European market from January 1, 2026, as every shipment entering the European Union will carry a carbon cost under the Carbon Border Adjustment Mechanism (CBAM), according to a report by Global Trade Res
India's pharmaceutical industry is set to record healthy revenue growth of 7-9 per cent in FY26, even as challenges in the United States market continue to weigh on performance, noted rating agency ICRA in its latest sector outlook.
New Delhi [India], Oct 5 (ANI): The growth and profitability of Indian pharmaceutical companies in current financial year will be constrained by regulatory interventions like price controls in domestic market and compulsory genericisation in overseas market, according to ICRA Ratings.